American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: Small animal

Goggs, Robert; Blais, Marie‐Claude; Brainard, Benjamin M.; Chan, Daniel L.; deLaforcade, Armelle M.; Rozanski, Elizabeth A.; Sharp, Claire R.

doi:10.1111/vec.12801

Cited by 49 publications

(94 citation statements)

References 352 publications

(502 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An outline of our recommendations relating to antithrombotic treatment is shown in Figure . Additional guidance on the use of antithrombotic drugs in dogs is provided in the CURATIVE guidelines …”

Section: Results and Recommendationsmentioning

confidence: 99%

ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

Swann

Garden

Fellman

et al. 2019

Veterinary Internal Medicne

Self Cite

187

View full text Add to dashboard Cite

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians as to the optimal regimen to employ and maintain after diagnosis of the disease. To address this inconsistency and provide evidence‐based guidelines for treatment of IMHA in dogs, we identified and extracted data from studies published in the veterinary literature. We developed a novel tool for evaluation of evidence quality, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods. In combination with our clinical experience and comparable guidelines for humans afflicted with autoimmune hemolytic anemia, we used the conclusions of this process to make a set of clinical recommendations regarding treatment of IMHA in dogs, which we refined subsequently by conducting several iterations of Delphi review. Additionally, we considered emerging treatments for IMHA in dogs and highlighted areas deserving of future research. Comments were solicited from several professional bodies to maximize clinical applicability before the recommendations were submitted for publication. The resulting document is intended to provide clinical guidelines for management of IMHA in dogs. These guidelines should be implemented pragmatically, with consideration of animal, owner, and veterinary factors that may vary among cases.

show abstract

Section: Results and Recommendationsmentioning

confidence: 99%

ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

Swann

Garden

Fellman

et al. 2019

Veterinary Internal Medicne

Self Cite

187

View full text Add to dashboard Cite

show abstract

“…D5. Echocardiography to assess the probability of PH should be considered in dogs at high risk for PE/PT/PTE that have developed clinical signs suggestive of PH particularly with evidence of hypoxemia and thoracic imaging that fails to identify another underlying cause for the respiratory signs. Consensus in 7/7 members of the panel and 5/5 advisory reviewers …”

Section: Guidelines For Diagnostic Evaluation Of Dogs With Suspected Phmentioning

confidence: 99%

ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs

Reinero

Visser

Kellihan

et al. 2020

Veterinary Internal Medicne

Self Cite

181

383

View full text Add to dashboard Cite

Pulmonary hypertension (PH), defined by increased pressure within the pulmonary vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of cardiovascular, respiratory, and systemic diseases. The purpose of this consensus statement is to provide a multidisciplinary approach to guidelines for the diagnosis, classification, treatment, and monitoring of PH in dogs. Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions. Dogs with PH can be classified into the following 6 groups: group 1, pulmonary arterial hypertension; group 2, left heart disease; group 3, respiratory disease/hypoxia; group 4, pulmonary emboli/pulmonary thrombi/pulmonary thromboemboli; group 5, parasitic disease (Dirofilaria and Angiostrongylus); and group 6, disorders that are multifactorial or with unclear mechanisms. The approach to treatment of PH focuses on strategies to decrease the risk of progression, complications, or both, recommendations to target underlying diseases or factors contributing to PH, and PH‐specific treatments. Dogs with PH should be monitored for improvement, static condition, or progression, and any identified underlying disorder should be addressed and monitored simultaneously.

show abstract

“…The interested reader is also referred to a recent consensus statement which summarises the indications for antithrombotic medication using the current evidence available (Goggs et al . ).…”

Section: Abnormalities Of Platelet Function Resulting In Haemorrhagementioning

confidence: 97%

“…Specific guidelines for the peri‐operative use of anti‐platelet medication are discussed in detail in the previously mentioned consensus statement and depends on the risk of thrombosis and the type of procedure (Goggs et al . ).…”

Section: Abnormalities Of Platelet Function Resulting In Haemorrhagementioning

confidence: 97%

See 1 more Smart Citation

Abnormal platelet activity in dogs and cats – impact and measurement

Gant

McBride

Humm

2020

J of Small Animal Practice

View full text Add to dashboard Cite

Abnormal platelet activity can either lead to bleeding tendencies or inappropriate thrombus formation and can occur secondarily to a wide variety of disease processes, with a range of clinical consequences and severity. This article will discuss the pathophysiology of platelet function abnormalities and consider a logical diagnostic approach applicable to veterinary practice. Recent advances in platelet function testing will then be discussed, with regards to detection of platelet dysfunction and tailoring of pharmacological manipulation. Although many of these tests are still confined to research or academic institutions, techniques for indirectly assessing platelet function are starting to become more widely available. Although we still require further research to develop guidelines for the use of these tests in clinical decision‐making, the recent advances in this field are an exciting step forward in being able to detect and manage platelet dysfunction in both primary care and referral practice.

show abstract

American College of Veterinary Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: Small animal

Cited by 49 publications

References 352 publications

ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs

Abnormal platelet activity in dogs and cats – impact and measurement

Contact Info

Product

Resources

About